FDA drug alerts in endocrinology, including drug approvals, drug warnings, FDA medical device recalls, and FDA drug label ...

Cancer patients who sought a virtual second opinion received a recommendation for a treatment change more than half the time, researchers found.

Women with adverse pregnancy outcomes (APOs) have an increased risk for cardiovascular disease (CVD), as do their APO-free sisters.

Following VAD implantation, children with congenital heart disease are significantly more likely to have major adverse events.

Semaglutide use in patients with type 2 diabetes moderately increases the risk of nonarteritic anterior ischemic optic neuropathy.

A study has found that, in the United States, the rate of sudden cardiac death is increasing among adults aged 25 to 44 years.

Patients with pregnancy-related hypertension (HTN) or diabetes are more likely to be screened for diabetes and dyslipidemia after delivery.